Latest CALA reports update at 2022-11-14: 2022-Q3 ∙ 2021-Q4 ∙ 2021-Q3

Calithera Biosciences CALA

$ 0.37 -10.95%

Calithera Biosciences Financial Statements 2011-2024 | CALA

Annual Financial Statements Calithera Biosciences

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	960 M	197 M	293 M	160 M	262 M	132 M	90.2 M	357 M	-	-	-
Shares	73.9 M	68.8 M	47.3 M	36.6 M	33 M	19.5 M	18 M	17.9 M	-	-	-
Historical Prices	13.3	98.2	114	80.2	167	65	153	404	-	-	-
Net Income	-115 M	-90.1 M	-89.9 M	-54.6 M	-27.8 M	-38 M	-32.6 M	-21.7 M	-12.4 M	-7.98 M	-
Revenue	9.75 M	-	-	22.3 M	26 M	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-115 M	-91.4 M	-92.9 M	-57.3 M	-29.7 M	-38.3 M	-32.8 M	-21.7 M	-12.4 M	-7.98 M	-
Interest Expense	-	-	-	2.65 M	1.86 M	330 K	175 K	9 K	1 K	-	-
EBITDA	-115 M	-91 M	-92.4 M	-56.8 M	-29.3 M	-38 M	-32.4 M	-21.4 M	-12.1 M	-7.71 M	-
Operating Expenses	125 M	91.4 M	92.9 M	79.5 M	55.6 M	38.3 M	32.8 M	21.7 M	-	-	-
General and Administrative Expenses	20.9 M	20.4 M	16.6 M	13.3 M	12.5 M	10.6 M	9.07 M	5.35 M	2.48 M	1.42 M	-

All numbers in USD currency

Quarterly Income Statement Calithera Biosciences

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	4.86 M	4.86 M	78.5 M	3.86 M	3.71 M	3.7 M	72.2 M	70.7 M	70.6 M	69.5 M	64.6 M	63.5 M	53.8 M	41.3 M	38.9 M	38.8 M	36.4 M	35.9 M	35.8 M	35.8 M	35.5 M	35.3 M	25.3 M	21.5 M	19.5 M	19 M	18.4 M	18.2 M	18.1 M	18 M	17.9 M	17.9 M	311 K	227 K	182 K	161 K	97 K	-	-	-	-	-	-	-	-	-	-
Net Income	-	-9.8 M	-9.08 M	-13.8 M	-	-11.2 M	-14.3 M	-20.4 M	-	-22.7 M	-20.4 M	-24.4 M	-21.7 M	-20.3 M	-24.2 M	-23.7 M	-19.5 M	-18.8 M	-3.08 M	-13.2 M	-11 M	-6.07 M	-5.19 M	-5.59 M	-9.52 M	-8.54 M	-10.4 M	-9.58 M	-8.07 M	-8.9 M	-7.82 M	-7.86 M	-6.83 M	-5.24 M	-5.49 M	-4.15 M	-	-3.32 M	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	6.75 M	3 M	-	-	-	-	-	-	-	-	-	-	22.3 M	17.1 M	5.19 M	7.25 M	7.25 M	7.26 M	4.19 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-9.53 M	-11.4 M	-13.8 M	-	-11.2 M	-14.3 M	-20.8 M	-	-22.9 M	-20.8 M	-25.1 M	-	-21.1 M	-24.9 M	-24.4 M	-	-19.5 M	-3.74 M	-13.8 M	-	-6.65 M	-5.74 M	-5.76 M	-	-8.63 M	-10.4 M	-9.66 M	-	-8.95 M	-7.87 M	-7.87 M	-	-5.24 M	-5.49 M	-4.15 M	-	-3.32 M	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-276 K	2.3 M	-	-	-22 K	-4 K	-	-	-	-	-	-	-	-	716 K	-	658 K	663 K	606 K	-	582 K	541 K	169 K	-	88 K	83 K	75 K	-	50 K	56 K	9 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-9.34 M	-11.2 M	-13.8 M	-	-10.9 M	-14.2 M	-20.7 M	-	-22.6 M	-20.6 M	-25 M	-	-20.8 M	-24.7 M	-24.3 M	-	-19.1 M	-3.49 M	-13.7 M	-	-6.4 M	-5.57 M	-5.68 M	-	-8.41 M	-10.3 M	-9.57 M	-	-8.63 M	-7.65 M	-7.76 M	-	-4.98 M	-5.34 M	-4.08 M	-	-3.11 M	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	9.53 M	11.4 M	13.8 M	-	17.9 M	17.3 M	20.8 M	-	22.9 M	20.8 M	25.1 M	22.5 M	21.1 M	24.9 M	24.4 M	20.2 M	19.5 M	20.8 M	19 M	18.8 M	13.9 M	13 M	9.95 M	9.6 M	8.63 M	10.4 M	9.66 M	8.13 M	8.95 M	7.87 M	7.87 M	6.84 M	5.24 M	5.49 M	4.15 M	-	3.32 M	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	3.08 M	3.62 M	4.26 M	-	6.34 M	4.49 M	5.43 M	-	4.74 M	5.1 M	4.95 M	-	3.91 M	3.98 M	4.16 M	-	3.09 M	3.5 M	3.51 M	-	3.07 M	2.85 M	3.31 M	-	2.32 M	2.66 M	2.59 M	-	2.2 M	2.34 M	2.24 M	-	1.35 M	1.31 M	832 K	-	583 K	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency